Title : The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation.

Pub. Date : 2020 Aug 18

PMID : 32808031






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Thus, our findings suggest that tofacitinib is quite effective in protecting from colitis by inhibition of a bundle of T cell derived cytokines like IL-5, IL-6, IL-9, IL-13 and IL-17A. tofacitinib interleukin 17A Homo sapiens